Sleep disruption in patients with active and treated endogenous Cushing’s syndrome
Patients with treated CS report improved sleep quality compared to those with active disease, but almost half of treated patients still report sleep challenges. The need for sleep medications, reported by one third of patients, was not different after CS treatment. Ongoing mood disturbances may play a role in persistent sleep disruption. Further work should focus on determinants of sleep impairments in treated CS patients.
Authors
- Andrew Lin (ORCID: https://orcid.org/0000-0003-0659-261X)
- Eliza B. Geer (ORCID: https://orcid.org/0000-0003-3722-1889)
- Hannah Robins (ORCID: https://orcid.org/0000-0003-4924-7816)
- Sheila N. Garland (ORCID: https://orcid.org/0000-0002-6119-318X)
- Jun J. J. Mao (ORCID: https://orcid.org/0000-0001-9229-0380)
- Vanessa Cohen
- Christine Garcia
- Marc A. Cohen (ORCID: https://orcid.org/0000-0002-6104-7967)
- Viviane Tabar (ORCID: https://orcid.org/0000-0002-1284-1670)
- Hannah Baratz (ORCID: https://orcid.org/0000-0003-3981-1460)
- Li Q (ORCID: https://orcid.org/0000-0003-3060-3323)
- Maria Sazo
- I. Monteiro Grillo
Institutions
- Memorial University of Newfoundland (CA)
- Memorial Sloan Kettering Cancer Center (US)
- Lake Erie College of Osteopathic Medicine (US)
- Suffolk University (US)
- Mount Sinai Medical Center (US)
Publication Details
- Journal
- Pituitary
- Published
- 2024-09-09
- DOI
- https://doi.org/10.1007/s11102-024-01450-8
- Citations
- 4
- Primary Topic
- Pituitary Gland Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.43
Funders
- National Institutes of Health
- National Cancer Institute